| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-leucine binding | 2.06e-06 | 7 | 79 | 3 | GO:0070728 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.55e-05 | 2 | 79 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.53e-04 | 5 | 79 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.81e-04 | 227 | 79 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.99e-04 | 33 | 79 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 3.20e-04 | 7 | 79 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | kinase binding | SLC12A6 TRADD PTPN14 SASH1 PIK3R2 PARP8 PPP1R9A CLTC PRKN GNAT1 EP300 ADD3 | 4.05e-04 | 969 | 79 | 12 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | SLC12A6 TRADD PTPN14 SASH1 PIK3R2 PPP1R9A CLTC PRKN GNAT1 EP300 ADD3 | 6.25e-04 | 873 | 79 | 11 | GO:0019901 |
| GeneOntologyBiologicalProcess | cellular response to L-leucine | 1.54e-07 | 13 | 81 | 4 | GO:0071233 | |
| GeneOntologyBiologicalProcess | response to L-leucine | 3.87e-07 | 16 | 81 | 4 | GO:0043201 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 2.60e-06 | 222 | 81 | 8 | GO:0008154 | |
| GeneOntologyBiologicalProcess | actin filament organization | ABI1 PIK3R2 PPP1R9A CAPZB TENM1 PRKN PSTPIP1 MYO15A PREX1 CNN3 ADD3 | 4.73e-06 | 509 | 81 | 11 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 9.86e-06 | 190 | 81 | 7 | GO:0030041 | |
| GeneOntologyBiologicalProcess | cellular response to leucine starvation | 1.25e-05 | 12 | 81 | 3 | GO:1990253 | |
| GeneOntologyBiologicalProcess | negative regulation of spontaneous neurotransmitter secretion | 1.52e-05 | 2 | 81 | 2 | GO:1904049 | |
| GeneOntologyBiologicalProcess | negative regulation of primary amine oxidase activity | 1.52e-05 | 2 | 81 | 2 | GO:1902283 | |
| GeneOntologyBiologicalProcess | regulation of response to reactive oxygen species | 1.62e-05 | 13 | 81 | 3 | GO:1901031 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | 2.70e-05 | 400 | 81 | 9 | GO:0010506 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 3.46e-05 | 156 | 81 | 6 | GO:0030833 | |
| GeneOntologyBiologicalProcess | regulation of response to oxidative stress | 3.46e-05 | 47 | 81 | 4 | GO:1902882 | |
| GeneOntologyBiologicalProcess | regulation of spontaneous neurotransmitter secretion | 4.56e-05 | 3 | 81 | 2 | GO:1904048 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | PIK3R2 CLTC MTMR8 NAGLU SESN3 PRKN SESN2 SESN1 EP300 EXOC8 TPCN1 | 4.58e-05 | 650 | 81 | 11 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | PIK3R2 CLTC MTMR8 NAGLU SESN3 PRKN SESN2 SESN1 EP300 EXOC8 TPCN1 | 4.58e-05 | 650 | 81 | 11 | GO:0006914 |
| GeneOntologyBiologicalProcess | protein polymerization | 5.01e-05 | 334 | 81 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ABI1 PIK3R2 PPP1R9A CAPZB TENM1 PRKN PSTPIP1 MYO15A PREX1 EP300 CNN3 ADD3 | 6.69e-05 | 803 | 81 | 12 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 6.99e-05 | 177 | 81 | 6 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 7.67e-05 | 180 | 81 | 6 | GO:0030832 | |
| GeneOntologyBiologicalProcess | regulation of macroautophagy | 9.19e-05 | 186 | 81 | 6 | GO:0016241 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 1.32e-04 | 384 | 81 | 8 | GO:0032956 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 1.48e-04 | 291 | 81 | 7 | GO:0072593 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 1.78e-04 | 300 | 81 | 7 | GO:0110053 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ABI1 PIK3R2 PPP1R9A CAPZB TENM1 PRKN PSTPIP1 MYO15A PREX1 EP300 CNN3 ADD3 | 2.21e-04 | 912 | 81 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | 2.67e-04 | 426 | 81 | 8 | GO:0032535 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.98e-04 | 231 | 81 | 6 | GO:0032271 | |
| GeneOntologyBiologicalProcess | regulation of spontaneous synaptic transmission | 3.16e-04 | 7 | 81 | 2 | GO:0150003 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 3.22e-04 | 438 | 81 | 8 | GO:0032970 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 3.22e-04 | 438 | 81 | 8 | GO:1902903 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ABI1 PIK3R2 PPP1R9A CAPZB TENM1 PRKN PSTPIP1 MYO15A PREX1 EP300 CNN3 ADD3 | 3.43e-04 | 957 | 81 | 12 | GO:0097435 |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 4.33e-04 | 161 | 81 | 5 | GO:0071230 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 4.40e-04 | 579 | 81 | 9 | GO:0051493 | |
| GeneOntologyBiologicalProcess | positive regulation of macroautophagy | 4.74e-04 | 92 | 81 | 4 | GO:0016239 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway by p53 class mediator | 4.94e-04 | 93 | 81 | 4 | GO:0072332 | |
| GeneOntologyBiologicalProcess | negative regulation of neurotransmitter secretion | 5.39e-04 | 9 | 81 | 2 | GO:0046929 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 6.00e-04 | 173 | 81 | 5 | GO:0010508 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 6.65e-04 | 177 | 81 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB6 TRADD FAT4 ABI1 FBN1 IGF2R PIK3R2 SESN3 ACVR1C USP15 CDH3 AR EP300 | 6.85e-04 | 1186 | 81 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 7.00e-04 | 102 | 81 | 4 | GO:1903432 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 7.02e-04 | 618 | 81 | 9 | GO:0090066 | |
| GeneOntologyBiologicalProcess | behavior | C1QL1 NAGLU AOC3 SLITRK5 BBS2 PRKN GNAT1 MYO15A AR EP300 PREX2 | 7.02e-04 | 891 | 81 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 7.02e-04 | 377 | 81 | 7 | GO:0062197 | |
| GeneOntologyCellularComponent | GATOR2 complex | 1.20e-05 | 12 | 81 | 3 | GO:0061700 | |
| GeneOntologyCellularComponent | Seh1-associated complex | 3.03e-05 | 16 | 81 | 3 | GO:0035859 | |
| Domain | AhpD-like | 7.28e-08 | 3 | 79 | 3 | IPR029032 | |
| Domain | PA26 | 7.28e-08 | 3 | 79 | 3 | PF04636 | |
| Domain | Sestrin | 7.28e-08 | 3 | 79 | 3 | IPR006730 | |
| Domain | - | 7.28e-08 | 3 | 79 | 3 | 1.20.1290.10 | |
| Domain | YD | 7.24e-07 | 5 | 79 | 3 | IPR006530 | |
| Domain | SAM_2 | 3.23e-05 | 43 | 79 | 4 | PF07647 | |
| Domain | Tox-GHH_dom | 1.05e-04 | 4 | 79 | 2 | IPR028916 | |
| Domain | Ten_N | 1.05e-04 | 4 | 79 | 2 | IPR009471 | |
| Domain | Ten_N | 1.05e-04 | 4 | 79 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.05e-04 | 4 | 79 | 2 | PS51361 | |
| Domain | NtCtMGAM_N | 1.05e-04 | 4 | 79 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 1.05e-04 | 4 | 79 | 2 | IPR031727 | |
| Domain | Tox-GHH | 1.05e-04 | 4 | 79 | 2 | PF15636 | |
| Domain | Glyco_hydro_31_AS | 2.62e-04 | 6 | 79 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 3.66e-04 | 7 | 79 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 3.66e-04 | 7 | 79 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 3.66e-04 | 7 | 79 | 2 | PS00129 | |
| Domain | EGF_3 | 4.81e-04 | 235 | 79 | 6 | PS50026 | |
| Domain | EGF | 4.81e-04 | 235 | 79 | 6 | SM00181 | |
| Domain | Trefoil | 4.87e-04 | 8 | 79 | 2 | PF00088 | |
| Domain | SAM | 5.28e-04 | 88 | 79 | 4 | SM00454 | |
| Domain | - | 5.96e-04 | 39 | 79 | 3 | 2.120.10.30 | |
| Domain | P_TREFOIL_2 | 6.24e-04 | 9 | 79 | 2 | PS51448 | |
| Domain | PD | 6.24e-04 | 9 | 79 | 2 | SM00018 | |
| Domain | EGF-like_dom | 6.52e-04 | 249 | 79 | 6 | IPR000742 | |
| Domain | SAM_DOMAIN | 7.05e-04 | 95 | 79 | 4 | PS50105 | |
| Domain | SAM | 7.62e-04 | 97 | 79 | 4 | IPR001660 | |
| Domain | EGF-like_CS | 8.33e-04 | 261 | 79 | 6 | IPR013032 | |
| Domain | EGF_2 | 9.02e-04 | 265 | 79 | 6 | PS01186 | |
| Domain | - | 9.48e-04 | 11 | 79 | 2 | 4.10.110.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.70e-04 | 46 | 79 | 3 | IPR011042 | |
| Domain | - | 1.06e-03 | 106 | 79 | 4 | 1.10.150.50 | |
| Domain | P_trefoil_dom | 1.13e-03 | 12 | 79 | 2 | IPR000519 | |
| Domain | NHL | 1.34e-03 | 13 | 79 | 2 | PS51125 | |
| Domain | Glycoside_hydrolase_SF | 1.47e-03 | 53 | 79 | 3 | IPR017853 | |
| Domain | SAM/pointed | 1.53e-03 | 117 | 79 | 4 | IPR013761 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 79 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.89e-03 | 124 | 79 | 4 | IPR001881 | |
| Domain | SH3 | 2.22e-03 | 216 | 79 | 5 | SM00326 | |
| Domain | SH3 | 2.22e-03 | 216 | 79 | 5 | PS50002 | |
| Domain | Gal_mutarotase_SF_dom | 2.31e-03 | 17 | 79 | 2 | IPR011013 | |
| Domain | SH3_domain | 2.41e-03 | 220 | 79 | 5 | IPR001452 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | PF00610 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | PS50186 | |
| Domain | DEP | 3.86e-03 | 22 | 79 | 2 | SM00049 | |
| Domain | DEP_dom | 4.22e-03 | 23 | 79 | 2 | IPR000591 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 FAM13A PIK3R2 CLTC CAPZB SLITRK5 FAM135A PREX1 PREX2 ADD3 | 2.99e-05 | 439 | 65 | 10 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 FAM13A PIK3R2 CLTC CAPZB SLITRK5 FAM135A PREX1 PREX2 ADD3 | 3.69e-05 | 450 | 65 | 10 | M27078 |
| Pubmed | Sestrin1, 2, and 3 are dispensable for female fertility in mice. | 1.22e-08 | 3 | 81 | 3 | 38297375 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 12607115 | ||
| Pubmed | Sestrins are evolutionarily conserved mediators of exercise benefits. | 1.22e-08 | 3 | 81 | 3 | 31929512 | |
| Pubmed | Circulating Sestrin Levels Are Increased in Hypertension Patients. | 1.22e-08 | 3 | 81 | 3 | 32626541 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 31073887 | ||
| Pubmed | The functions and roles of sestrins in regulating human diseases. | 1.22e-08 | 3 | 81 | 3 | 34979914 | |
| Pubmed | Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. | 4.86e-08 | 4 | 81 | 3 | 22958918 | |
| Pubmed | SLC12A6 ABI1 PTPN14 IGF2R SASH1 PIK3R2 PPP1R9A SEC63 FAM135A ADD3 | 5.31e-08 | 421 | 81 | 10 | 36976175 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 26449471 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 25259925 | ||
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 25263562 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20694145 | ||
| Pubmed | Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. | 5.36e-06 | 2 | 81 | 2 | 20203043 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34369620 | ||
| Pubmed | P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. | 5.36e-06 | 2 | 81 | 2 | 18334636 | |
| Pubmed | Identification of the functional domains of ANT-1, a novel coactivator of the androgen receptor. | 5.36e-06 | 2 | 81 | 2 | 16414017 | |
| Pubmed | Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine. | 5.36e-06 | 2 | 81 | 2 | 35771919 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 28710285 | ||
| Pubmed | The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. | 5.36e-06 | 2 | 81 | 2 | 24852371 | |
| Pubmed | Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity. | 5.36e-06 | 2 | 81 | 2 | 31026186 | |
| Pubmed | Sestrins orchestrate cellular metabolism to attenuate aging. | 5.36e-06 | 2 | 81 | 2 | 24055102 | |
| Pubmed | [A study of recombinant human sestrin 1 and sestrin 2 proteins produced in a prokaryotic system]. | 5.36e-06 | 2 | 81 | 2 | 28707664 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32745318 | ||
| Pubmed | Sestrins induce natural killer function in senescent-like CD8+ T cells. | 5.36e-06 | 2 | 81 | 2 | 32231301 | |
| Pubmed | ENDOD1 ABCB7 GTF2I PIK3R2 CLTC SESN2 HCFC2 SEC63 NDUFS1 EP300 PREX2 ASF1A NXF1 | 1.15e-05 | 1327 | 81 | 13 | 32694731 | |
| Pubmed | The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. | 1.60e-05 | 3 | 81 | 2 | 11221880 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 30513371 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23172223 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 11437399 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 25377878 | ||
| Pubmed | Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis. | 1.60e-05 | 3 | 81 | 2 | 25749384 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 12404104 | ||
| Pubmed | Androgen pathway dysregulation in BRCA1-mutated breast tumors. | 1.60e-05 | 3 | 81 | 2 | 12779088 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 19818997 | ||
| Pubmed | Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. | 1.60e-05 | 3 | 81 | 2 | 26913956 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 37918578 | ||
| Pubmed | Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. | 1.60e-05 | 3 | 81 | 2 | 15060161 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31857853 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 2.18e-05 | 499 | 81 | 8 | 22810586 | |
| Pubmed | 2.34e-05 | 504 | 81 | 8 | 34432599 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | NID2 ENDOD1 ABCB7 PTPN14 FBN1 IGF2R PIGK CLTC NAGLU PRPF6 SEC63 NDUFS1 EP300 | 2.94e-05 | 1451 | 81 | 13 | 30550785 |
| Pubmed | USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy. | 3.20e-05 | 4 | 81 | 2 | 31432739 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 3.20e-05 | 4 | 81 | 2 | 10225957 | |
| Pubmed | Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. | 3.20e-05 | 4 | 81 | 2 | 15105503 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 12039962 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 23449976 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 32668201 | ||
| Pubmed | Rho GEFs and cancer: linking gene expression and metastatic dissemination. | 3.20e-05 | 4 | 81 | 2 | 23033535 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 24480624 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 20448036 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 3.20e-05 | 4 | 81 | 2 | 12000766 | |
| Pubmed | Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review. | 3.20e-05 | 4 | 81 | 2 | 14769635 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 10779504 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MSRA SLC12A6 ENDOD1 PHYKPL DNAJC13 GTF2I FAM13A PPP1R9A PRKN USP15 SESN1 AR EP300 | 3.84e-05 | 1489 | 81 | 13 | 28611215 |
| Pubmed | 4.29e-05 | 549 | 81 | 8 | 38280479 | ||
| Pubmed | 4.93e-05 | 560 | 81 | 8 | 35241646 | ||
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 5.22e-05 | 31 | 81 | 3 | 23602572 | |
| Pubmed | p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. | 5.33e-05 | 5 | 81 | 2 | 18692468 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 18487222 | ||
| Pubmed | The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins. | 5.33e-05 | 5 | 81 | 2 | 21262840 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 29330382 | ||
| Pubmed | Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor. | 5.33e-05 | 5 | 81 | 2 | 11387476 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 5.51e-05 | 569 | 81 | 8 | 30639242 | |
| Pubmed | 6.81e-05 | 93 | 81 | 4 | 27689697 | ||
| Pubmed | P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation. | 7.99e-05 | 6 | 81 | 2 | 25538043 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 28549433 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 20525073 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 34429451 | ||
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 17970752 | ||
| Pubmed | 8.23e-05 | 777 | 81 | 9 | 35844135 | ||
| Pubmed | 9.03e-05 | 100 | 81 | 4 | 10048485 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.01e-04 | 621 | 81 | 8 | 22794259 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ENDOD1 FAT4 ABCB7 FBN1 IGF2R PIGK NAGLU SLITRK5 SEC63 USP15 TPCN1 | 1.06e-04 | 1201 | 81 | 11 | 35696571 |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 21178006 | ||
| Pubmed | P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. | 1.12e-04 | 7 | 81 | 2 | 17565979 | |
| Pubmed | Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals. | 1.12e-04 | 7 | 81 | 2 | 31929511 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 12915301 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MSRA DNAJC13 MXRA5 ABI1 IGF2R SH3BGRL CLTC NAGLU CAPZB MYO15A | 1.25e-04 | 1016 | 81 | 10 | 19056867 |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 32479599 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 27903893 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 10331952 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 23274085 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 24659802 | ||
| Pubmed | DNAJC13 ABCB7 PTPN14 IGF2R PIK3R2 CLTC BBS2 PRPF6 SEC63 FAM135A NDUFS1 ADD3 | 1.64e-04 | 1487 | 81 | 12 | 33957083 | |
| Pubmed | 1.82e-04 | 506 | 81 | 7 | 30890647 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 18765668 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 38713721 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ENDOD1 DNAJC13 ABI1 PTPN14 GTF2I CAPZB BBS2 PRPF6 USP15 NDUFS1 EXOC8 | 2.41e-04 | 1321 | 81 | 11 | 27173435 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.58e-04 | 536 | 81 | 7 | 15840001 | |
| Pubmed | 2.64e-04 | 538 | 81 | 7 | 10512203 | ||
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 20598684 | ||
| Pubmed | Transforming growth factor Beta2 is required for valve remodeling during heart development. | 3.48e-04 | 12 | 81 | 2 | 21780244 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 26405179 | ||
| Pubmed | 3.56e-04 | 259 | 81 | 5 | 31162944 | ||
| Pubmed | 4.27e-04 | 150 | 81 | 4 | 32423001 | ||
| Pubmed | 4.76e-04 | 276 | 81 | 5 | 28319085 | ||
| Pubmed | PRSS50 is a testis protease responsible for proper sperm tail formation and function. | 4.79e-04 | 14 | 81 | 2 | 33913480 | |
| Pubmed | Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo. | 4.79e-04 | 14 | 81 | 2 | 31749402 | |
| Pubmed | 4.95e-04 | 156 | 81 | 4 | 29961565 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 24090483 | ||
| Interaction | RND3 interactions | 1.21e-06 | 273 | 79 | 9 | int:RND3 | |
| Interaction | RAC1 interactions | TRADD ABI1 PTPN14 IGF2R FAM13A PIK3R2 PPP1R9A CLTC CAPZB SLITRK5 PRKN HABP2 PREX1 NDUFS1 PREX2 ADD3 | 2.99e-06 | 1063 | 79 | 16 | int:RAC1 |
| Interaction | NPRL3 interactions | 3.35e-06 | 104 | 79 | 6 | int:NPRL3 | |
| Interaction | CAV1 interactions | SLC12A6 ENDOD1 TRADD PTPN14 IGF2R PIK3R2 PPP1R9A CLTC PRKN FAM135A AR NXF1 ADD3 | 4.42e-06 | 724 | 79 | 13 | int:CAV1 |
| Interaction | RHOH interactions | SLC12A6 ABCB7 IGF2R PIK3R2 CLTC SLITRK5 PRKN FAM135A PREX1 NDUFS1 ADD3 | 4.86e-06 | 512 | 79 | 11 | int:RHOH |
| Interaction | TRERF1 interactions | 8.21e-06 | 33 | 79 | 4 | int:TRERF1 | |
| Interaction | CTTN interactions | ABI1 BRCA2 SH3BGRL PPP1R9A CAPZB PRKN PRPF6 EP300 ASF1A NXF1 | 1.01e-05 | 450 | 79 | 10 | int:CTTN |
| Interaction | RHOF interactions | FAT4 ABCB7 IGF2R PIGK PIK3R2 PPP1R9A CLTC CAPZB SLITRK5 FAM135A NXF1 ADD3 | 1.15e-05 | 673 | 79 | 12 | int:RHOF |
| Interaction | RHOA interactions | FAT4 ABCB7 PTPN14 IGF2R PIGK PIK3R2 PPP1R9A CLTC SLITRK5 SEC63 CDH3 FAM135A PREX1 NDUFS1 PREX2 ADD3 | 1.37e-05 | 1199 | 79 | 16 | int:RHOA |
| Interaction | RHOB interactions | SLC12A6 FAT4 ABCB7 ABI1 PTPN14 IGF2R PIK3R2 PPP1R9A CLTC SLITRK5 FAM135A NDUFS1 ADD3 | 2.16e-05 | 840 | 79 | 13 | int:RHOB |
| Interaction | EPHA2 interactions | EPHB6 SLC12A6 ABI1 PTPN14 IGF2R SASH1 PIK3R2 PPP1R9A CLTC SEC63 FAM135A ADD3 | 2.22e-05 | 719 | 79 | 12 | int:EPHA2 |
| Interaction | WDR24 interactions | 2.40e-05 | 43 | 79 | 4 | int:WDR24 | |
| Interaction | NELFA interactions | 2.47e-05 | 88 | 79 | 5 | int:NELFA | |
| Interaction | RAC3 interactions | FAT4 ABI1 IGF2R PIK3R2 PPP1R9A CLTC SLITRK5 PRKN FAM135A AR ADD3 | 2.85e-05 | 619 | 79 | 11 | int:RAC3 |
| Interaction | MCMBP interactions | 3.53e-05 | 157 | 79 | 6 | int:MCMBP | |
| Interaction | CSRNP3 interactions | 4.54e-05 | 3 | 79 | 2 | int:CSRNP3 | |
| Interaction | HIRA interactions | 4.67e-05 | 165 | 79 | 6 | int:HIRA | |
| Interaction | RHOG interactions | SLC12A6 ABCB7 IGF2R TENM4 PIK3R2 PPP1R9A CLTC SLITRK5 PRKN FAM135A NDUFS1 PREX2 ADD3 | 4.95e-05 | 910 | 79 | 13 | int:RHOG |
| Interaction | PRPSAP2 interactions | 5.04e-05 | 102 | 79 | 5 | int:PRPSAP2 | |
| Interaction | CCAR2 interactions | 5.23e-05 | 337 | 79 | 8 | int:CCAR2 | |
| Interaction | RBM14 interactions | 5.87e-05 | 553 | 79 | 10 | int:RBM14 | |
| Interaction | DUS3L interactions | 6.88e-05 | 56 | 79 | 4 | int:DUS3L | |
| Interaction | ABL1 interactions | 7.04e-05 | 259 | 79 | 7 | int:ABL1 | |
| Interaction | WASF3 interactions | 7.38e-05 | 57 | 79 | 4 | int:WASF3 | |
| Interaction | RHOD interactions | IGF2R PIK3R2 PPP1R9A CLTC CAPZB SLITRK5 SEC63 FAM135A NDUFS1 ADD3 | 7.78e-05 | 572 | 79 | 10 | int:RHOD |
| Interaction | RAB35 interactions | SLC12A6 ABI1 PTPN14 IGF2R PIK3R2 PPP1R9A PRKN SEC63 FAM135A ADD3 | 7.89e-05 | 573 | 79 | 10 | int:RAB35 |
| Interaction | HSP90AB1 interactions | EPHB6 ENDOD1 GTF2I IGF2R BRCA2 HLA-DRB4 CAPZB PRKN TSHZ1 MYO15A USP15 AR NXF1 | 8.52e-05 | 960 | 79 | 13 | int:HSP90AB1 |
| Interaction | ALDH18A1 interactions | 9.90e-05 | 189 | 79 | 6 | int:ALDH18A1 | |
| Interaction | FEN1 interactions | 1.11e-04 | 193 | 79 | 6 | int:FEN1 | |
| Interaction | FIG4 interactions | 1.25e-04 | 25 | 79 | 3 | int:FIG4 | |
| Interaction | SIM2 interactions | 1.25e-04 | 25 | 79 | 3 | int:SIM2 | |
| Interaction | SMARCC1 interactions | 1.30e-04 | 384 | 79 | 8 | int:SMARCC1 | |
| Interaction | CDC73 interactions | 1.34e-04 | 386 | 79 | 8 | int:CDC73 | |
| Interaction | STIP1 interactions | SLC12A6 DNAJC13 PTPN14 GTF2I CLTC MTMR8 CAPZB PRKN PRPF6 AR NDUFS1 EP300 ADD3 | 1.36e-04 | 1006 | 79 | 13 | int:STIP1 |
| Interaction | DNM2 interactions | 1.36e-04 | 288 | 79 | 7 | int:DNM2 | |
| Interaction | BECN1 interactions | 1.39e-04 | 201 | 79 | 6 | int:BECN1 | |
| Interaction | SRCAP interactions | 1.43e-04 | 127 | 79 | 5 | int:SRCAP | |
| Interaction | OCLN interactions | 1.46e-04 | 500 | 79 | 9 | int:OCLN | |
| Interaction | TDG interactions | 1.56e-04 | 69 | 79 | 4 | int:TDG | |
| Interaction | SEC24C interactions | 1.63e-04 | 207 | 79 | 6 | int:SEC24C | |
| Interaction | MYO6 interactions | 1.66e-04 | 398 | 79 | 8 | int:MYO6 | |
| Interaction | SON interactions | 1.67e-04 | 208 | 79 | 6 | int:SON | |
| Interaction | CDC42 interactions | FAT4 ABCB7 PTPN14 IGF2R PIK3R2 PPP1R9A CLTC CAPZB SLITRK5 PRKN FAM135A PREX1 NDUFS1 PREX2 ADD3 | 1.68e-04 | 1323 | 79 | 15 | int:CDC42 |
| Interaction | RHOJ interactions | ABCB7 PTPN14 IGF2R PIK3R2 PPP1R9A CLTC SLITRK5 FAM135A NDUFS1 ADD3 | 1.78e-04 | 633 | 79 | 10 | int:RHOJ |
| Interaction | SNX1 interactions | 1.85e-04 | 212 | 79 | 6 | int:SNX1 | |
| Interaction | PRDX4 interactions | 1.95e-04 | 214 | 79 | 6 | int:PRDX4 | |
| Interaction | DFFA interactions | 2.15e-04 | 75 | 79 | 4 | int:DFFA | |
| Interaction | TMED4 interactions | 2.38e-04 | 77 | 79 | 4 | int:TMED4 | |
| Interaction | WWTR1 interactions | 2.46e-04 | 422 | 79 | 8 | int:WWTR1 | |
| Interaction | HERC1 interactions | 2.56e-04 | 144 | 79 | 5 | int:HERC1 | |
| Interaction | PPP2R1A interactions | TRADD ABI1 PTPN14 FAM13A CLTC SERTAD4 CAPZB PRKN USP15 EP300 | 2.65e-04 | 665 | 79 | 10 | int:PPP2R1A |
| Interaction | CRKL interactions | 2.68e-04 | 227 | 79 | 6 | int:CRKL | |
| Interaction | ACTB interactions | ABI1 PIK3R2 SH3BGRL PPP1R9A CAPZB PRKN PSTPIP1 USP15 AR NDUFS1 EP300 CNN3 ADD3 | 2.81e-04 | 1083 | 79 | 13 | int:ACTB |
| Interaction | ARPC4-TTLL3 interactions | 2.91e-04 | 33 | 79 | 3 | int:ARPC4-TTLL3 | |
| Interaction | ETV5 interactions | 2.91e-04 | 33 | 79 | 3 | int:ETV5 | |
| Interaction | MIOS interactions | 3.18e-04 | 83 | 79 | 4 | int:MIOS | |
| Interaction | LGALS1 interactions | 3.25e-04 | 332 | 79 | 7 | int:LGALS1 | |
| Interaction | TES interactions | 3.25e-04 | 332 | 79 | 7 | int:TES | |
| Interaction | RAB2A interactions | 3.70e-04 | 567 | 79 | 9 | int:RAB2A | |
| Interaction | HPS6 interactions | 3.77e-04 | 36 | 79 | 3 | int:HPS6 | |
| Interaction | PPP1CA interactions | 3.80e-04 | 696 | 79 | 10 | int:PPP1CA | |
| Interaction | MEF2D interactions | 3.80e-04 | 87 | 79 | 4 | int:MEF2D | |
| Interaction | SEPTIN8 interactions | 3.80e-04 | 87 | 79 | 4 | int:SEPTIN8 | |
| Interaction | DDX19A interactions | 3.97e-04 | 88 | 79 | 4 | int:DDX19A | |
| Interaction | SEPTIN6 interactions | 3.97e-04 | 88 | 79 | 4 | int:SEPTIN6 | |
| Interaction | C1QTNF9 interactions | 4.09e-04 | 37 | 79 | 3 | int:C1QTNF9 | |
| Interaction | RND1 interactions | 4.11e-04 | 246 | 79 | 6 | int:RND1 | |
| Interaction | GLUL interactions | 4.16e-04 | 160 | 79 | 5 | int:GLUL | |
| Interaction | EEA1 interactions | 4.40e-04 | 162 | 79 | 5 | int:EEA1 | |
| Cytoband | 17q21 | 1.95e-04 | 63 | 81 | 3 | 17q21 | |
| Cytoband | Xq13.3 | 5.72e-04 | 20 | 81 | 2 | Xq13.3 | |
| Cytoband | 12q23.3 | 1.76e-03 | 35 | 81 | 2 | 12q23.3 | |
| Cytoband | 11q21 | 2.77e-03 | 44 | 81 | 2 | 11q21 | |
| GeneFamily | Sterile alpha motif domain containing | 1.02e-04 | 88 | 50 | 4 | 760 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 1.11e-03 | 18 | 50 | 2 | 1372 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 8.11e-03 | 49 | 50 | 2 | 584 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.44e-03 | 50 | 50 | 2 | 1293 | |
| GeneFamily | PDZ domain containing | 8.55e-03 | 152 | 50 | 3 | 1220 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | SLC41A2 PTPN14 ELL2 SASH1 FAM13A SH3BGRL CDH3 PREX1 AR PRTFDC1 | 1.12e-05 | 583 | 80 | 10 | M17454 |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 3.16e-05 | 197 | 80 | 6 | M9916 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | 3.25e-05 | 198 | 80 | 6 | M5776 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MXRA5 ELL2 FBN1 SASH1 FAM13A PARP8 TSHZ1 SEC63 SESN1 ADD3 TPCN1 | 3.33e-05 | 807 | 80 | 11 | M16651 |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_UP | 3.35e-05 | 199 | 80 | 6 | M6289 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 3.35e-05 | 199 | 80 | 6 | M5159 | |
| Coexpression | GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 3.44e-05 | 200 | 80 | 6 | M9677 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP | 3.44e-05 | 200 | 80 | 6 | M9886 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_DN | 3.44e-05 | 200 | 80 | 6 | M5744 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.01e-06 | 184 | 80 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-05 | 168 | 80 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 1.32e-05 | 80 | 80 | 4 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-05 | 180 | 80 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 184 | 80 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 80 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 190 | 80 | 5 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 190 | 80 | 5 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 191 | 80 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.43e-05 | 191 | 80 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.43e-05 | 191 | 80 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.43e-05 | 191 | 80 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 191 | 80 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 192 | 80 | 5 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 195 | 80 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 196 | 80 | 5 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 196 | 80 | 5 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.89e-05 | 198 | 80 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Sigmoid-T_cell-Treg|T_cell / Region, Cell class and subclass | 2.89e-05 | 198 | 80 | 5 | e2d2f9f209f77d0c48cfe3e9902c0ae0795511b2 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.89e-05 | 198 | 80 | 5 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 198 | 80 | 5 | d9ffc6589ed510ffa60c591f2a0fe123210f1455 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-05 | 199 | 80 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-05 | 200 | 80 | 5 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.03e-05 | 200 | 80 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.03e-05 | 200 | 80 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 200 | 80 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-04 | 140 | 80 | 4 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.71e-04 | 154 | 80 | 4 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 158 | 80 | 4 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 160 | 80 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 2.32e-04 | 167 | 80 | 4 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | Tuft-tuft-1|World / Class top | 2.38e-04 | 168 | 80 | 4 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-04 | 169 | 80 | 4 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 171 | 80 | 4 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.60e-04 | 172 | 80 | 4 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 173 | 80 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 175 | 80 | 4 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.78e-04 | 175 | 80 | 4 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 175 | 80 | 4 | 2f43883d7c89f09b0579a390a7431f1f9b832582 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 175 | 80 | 4 | da92eb8af0c7c65fed4a1d960708240f35dd997d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.78e-04 | 175 | 80 | 4 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 177 | 80 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-04 | 177 | 80 | 4 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 177 | 80 | 4 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-04 | 177 | 80 | 4 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 178 | 80 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 180 | 80 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-04 | 180 | 80 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.16e-04 | 181 | 80 | 4 | c783c2ecca7ab8e07646fa92dc7d436d24939d03 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.22e-04 | 182 | 80 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.22e-04 | 182 | 80 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.22e-04 | 182 | 80 | 4 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.22e-04 | 182 | 80 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-04 | 183 | 80 | 4 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-04 | 183 | 80 | 4 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-04 | 183 | 80 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 3.29e-04 | 183 | 80 | 4 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 3.29e-04 | 183 | 80 | 4 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-04 | 183 | 80 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-04 | 183 | 80 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 3.29e-04 | 183 | 80 | 4 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-04 | 183 | 80 | 4 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-04 | 183 | 80 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 184 | 80 | 4 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 3.36e-04 | 184 | 80 | 4 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.43e-04 | 185 | 80 | 4 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.43e-04 | 185 | 80 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 185 | 80 | 4 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.43e-04 | 185 | 80 | 4 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.43e-04 | 185 | 80 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 186 | 80 | 4 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.50e-04 | 186 | 80 | 4 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.50e-04 | 186 | 80 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.50e-04 | 186 | 80 | 4 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.50e-04 | 186 | 80 | 4 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 186 | 80 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 186 | 80 | 4 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-04 | 186 | 80 | 4 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 187 | 80 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-04 | 187 | 80 | 4 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 187 | 80 | 4 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.57e-04 | 187 | 80 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | VE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 3.64e-04 | 188 | 80 | 4 | fa88ceb336e30de3585e62608527a0d44df74190 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 188 | 80 | 4 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 188 | 80 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 188 | 80 | 4 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 188 | 80 | 4 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | VE-Treg|VE / Condition, Cell_class and T cell subcluster | 3.64e-04 | 188 | 80 | 4 | ef048517dfe2fc995d13eb1f08106a487354a4cc | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 188 | 80 | 4 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.64e-04 | 188 | 80 | 4 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-04 | 189 | 80 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-04 | 189 | 80 | 4 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 190 | 80 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| Disease | Carcinoma of lung | 3.03e-05 | 23 | 78 | 3 | C0684249 | |
| Disease | Neoplasm of the genitourinary tract | 3.46e-05 | 24 | 78 | 3 | cv:C0042065 | |
| Disease | 1,5 anhydroglucitol measurement | 6.18e-05 | 29 | 78 | 3 | EFO_0008009 | |
| Disease | fear of minor pain measurement | 7.57e-05 | 31 | 78 | 3 | EFO_0008340 | |
| Disease | Prostatic Neoplasms | 2.24e-04 | 616 | 78 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.24e-04 | 616 | 78 | 8 | C0376358 | |
| Disease | Malignant tumor of prostate | 2.45e-04 | 9 | 78 | 2 | cv:C0376358 | |
| Disease | polyp of colon | 4.45e-04 | 56 | 78 | 3 | MONDO_0021400 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 4.48e-04 | 12 | 78 | 2 | C3160718 | |
| Disease | Benign tumor of pancreas | 5.28e-04 | 13 | 78 | 2 | C0347284 | |
| Disease | aortic measurement | 5.45e-04 | 251 | 78 | 5 | EFO_0020865 | |
| Disease | cutaneous melanoma, hair color | 6.01e-04 | 62 | 78 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | nephroblastoma (is_implicated_in) | 6.15e-04 | 14 | 78 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | birth weight | 6.66e-04 | 399 | 78 | 6 | EFO_0004344 | |
| Disease | prostate cancer (is_marker_for) | 7.91e-04 | 156 | 78 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Pancreatic carcinoma | 1.15e-03 | 19 | 78 | 2 | C0235974 | |
| Disease | Adenocarcinoma of prostate | 1.27e-03 | 20 | 78 | 2 | C0007112 | |
| Disease | Disorder of eye | 2.44e-03 | 212 | 78 | 4 | C0015397 | |
| Disease | Colorectal Carcinoma | 2.57e-03 | 702 | 78 | 7 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGDMYESANNRAEYY | 616 | Q09472 | |
| RQNYKDDFNAEYDEY | 541 | O00472 | |
| AYYDYQGSLEEQEER | 261 | Q9UEY8 | |
| RASAIAQDADQNYDY | 181 | Q86Z23 | |
| YYVNNEYTETELREN | 111 | Q9Y294 | |
| LLYNYDNQTGDRAEF | 4011 | Q6V0I7 | |
| EYHEQGSLYDYLNRN | 271 | Q8NER5 | |
| RASAIAQDADQNYDY | 201 | O75973 | |
| YEDEEAAVVQYNDPY | 421 | Q8IZP0 | |
| DYFYAYDVDIQNSEG | 131 | A6NFU0 | |
| NNAFDQYRDLYFEGG | 101 | P47756 | |
| YESELPQGFQDYYNL | 306 | Q16581 | |
| RAQGQYMYDEQGAEY | 36 | Q8IUZ5 | |
| SEAEADFYEQNSRYQ | 631 | P54802 | |
| YQGRYYDSLAQLEAQ | 266 | Q16853 | |
| VGYALDYNEYFRDLN | 196 | Q9NRG1 | |
| REGQTFYYAEDYHQQ | 196 | Q9UJ68 | |
| NQSTDYYYEENEMNG | 6 | Q9NPB9 | |
| AQEYRALYDYTAQNP | 361 | O43586 | |
| NDSEEFYYGGQVNYD | 131 | Q8N3A8 | |
| VEYGRYSNELYELQA | 91 | Q9Y5Z7 | |
| RYGYQNDAEISSLYD | 1206 | Q2M2H8 | |
| FERASEYQLNDSAGY | 136 | P11488 | |
| GYENEDNYANIRFRF | 256 | Q96EF0 | |
| EAETYYYLNQGGNCE | 1431 | Q9UKN7 | |
| YGYQNDSEIASLYDE | 1251 | O43451 | |
| RYGYQNDSEISSLYD | 2146 | O43451 | |
| QFVDYARQAEEAYGA | 476 | Q8WYN3 | |
| NTDYLDSDYQRGQLY | 131 | O94919 | |
| DQQMVQNGYYEETDY | 1091 | Q9P2D6 | |
| LQQYYAIYDSGDRQG | 391 | Q9UBU9 | |
| GALDEAAAYQSRDYY | 351 | P10275 | |
| ELDYEDYNSYEINID | 306 | Q9Y5H7 | |
| YAYGQSRQYLDDTEV | 621 | O94988 | |
| QYLVYNGDLVEYDAD | 181 | Q8IYI6 | |
| NVYGDDVEVDYRSYE | 111 | Q92643 | |
| LESDYNEDNLDYYDV | 306 | Q14112 | |
| QQYQDKSREYDQLYE | 451 | O00459 | |
| QYDYSYEDYNQEENT | 41 | Q14520 | |
| YNNSDLFYREVADGA | 106 | Q9BXC9 | |
| NTADYVGNYLYENNS | 1706 | P51587 | |
| YRNYYADNQTCDGEL | 1696 | P35555 | |
| YNQEEYARYNSDLGE | 61 | P13762 | |
| YDYRNIEGFVDLSDY | 151 | O75165 | |
| NYGYRHNAEERYDAF | 251 | Q86UW8 | |
| EESEDPDYYQYNIQA | 241 | P78347 | |
| YLNNSNYEEGDEYFD | 116 | Q9UHW9 | |
| DEDDAIYTYNGVVAY | 241 | P22223 | |
| QAEDEADYYYQLIDN | 96 | A0A0A0MS00 | |
| EYQEEDNSTYNFRWY | 741 | P11717 | |
| FGIRYDDYDYGEVNQ | 401 | P58004 | |
| RYDDYDYGEINQLLD | 416 | Q9Y6P5 | |
| QYNRYQQYGAEECVL | 311 | O60260 | |
| SLAYEYEREGLYEQA | 251 | Q15628 | |
| YDDIEGANYFQQANE | 656 | P28331 | |
| EDLNDTNYDEFNGYA | 71 | O94906 | |
| NQDLLDNSYYEQYIL | 401 | Q5K651 | |
| GNILDYQLRYYDQAE | 516 | O15197 | |
| GDYNQFDSQDFLREY | 151 | Q15678 | |
| LGYRYNNNGEYEESS | 1346 | Q8TCU6 | |
| NESQYRGDYDAFFEA | 71 | O75368 | |
| EEGLVNARFDYSYNN | 2031 | Q9UKZ4 | |
| DYANYNYCDGRETSE | 111 | Q96JW4 | |
| DYFETGYNERNNVNE | 316 | Q9NUC0 | |
| FNNERYEAQRYDGFL | 346 | O75027 | |
| DELEELINYYQDRGY | 1281 | Q00610 | |
| EYQDDYPRDYQYSDQ | 311 | Q15417 | |
| KLDQRGYNAQEYYDR | 721 | P11217 | |
| GLENLEYLQVDYNYI | 151 | O94991 | |
| RYDDYDYGEVNQLLE | 416 | P58005 | |
| GYINEQYEQYLQEEI | 131 | Q8IYM1 | |
| YKNYDYSEPGRNNEQ | 271 | Q9Y4E8 | |
| RYSYEYDADGQLQTV | 2191 | Q6N022 | |
| LGNIDDLAQQYADYY | 56 | O94885 | |
| TDREYQEYNPYEVLN | 96 | Q9UGP8 | |
| EGYYYRDNVSVEEFQ | 1416 | Q70Z35 | |
| GNDTYRINNKYDETY | 76 | Q9HDD0 | |
| EEGYYYLNNFDNILN | 621 | Q9ULQ1 | |
| AVGEEDDDYQAYYLN | 721 | A7E2V4 | |
| DDDYQAYYLNAQDGA | 726 | A7E2V4 | |
| DAIDRYYYENSDQPI | 796 | Q6ZSZ6 | |
| QYRQDADEEALYYTG | 406 | Q9NR99 | |
| VFNTYSNEDYDRRND | 466 | Q9ULJ8 |